Molecular Surveillance In Early Breast Cancer Using The Tumor-Informed ctDNA Assay Myriad Genetics Precise MRD Test; A Prospective Observational Multicenter Study (The MRD Molecular Surveillance Study)

Clinical trial NCT07475923 · WITHDRAWN

Trial details

NCT number: NCT07475923
Sponsor: M.D. Anderson Cancer Center
Status: WITHDRAWN
Study type: OBSERVATIONAL

Molecular Surveillance Breast Cancer ctDNA MRD Observational Study

Start date: 2026-04-09
Primary completion: 2026-04-09
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.